Cas:131-12-4 Pimpinellin manufacturer & supplier

Chemical Name:Pimpinellin

CAS.NO:131-12-4

Synonyms:5,6-Dimethoxy-2H-furo[2,3-h]chromen-2-one;2H-Furo[2,3-h]-1-benzopyran-2-one, 5,6-dimethoxy-;5,6-dimethoxyfuro[2,3-h]chromen-2-one;4-Hydroxy-6,7-dimethoxy-5-benzofuranacrylic Acid d-Lactone;5,6-Dimethoxy-2H-furo[2,3-h]-1-benzopyran-2-one;Pimpinellin

Molecular Formula:C₁₃H₁₀O₅

Molecular Weight:246.215

HS Code:2932999099

Physical and Chemical Properties:

Melting point:119°

Boiling point:441.0±45.0 °C at 760 mmHg

Density:1.4±0.1 g/cm3

Index of Refraction:1.612

PSA:61.81000

Exact Mass:246.052826

LogP:2.06

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5,6-Dimethoxy-2H-furo[2,3-h]chromen-2-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Pimpinellin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5,6-Dimethoxy-2H-furo[2,3-h]-1-benzopyran-2-one Use and application,5,6-Dimethoxy-2H-furo[2,3-h]-1-benzopyran-2-one technical grade,usp/ep/jp grade.

Related News: Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as bulk pharmaceutical chemicals (BPCs). Pimpinellin manufacturer It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion. Pimpinellin supplier It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion. Pimpinellin vendor Therefore, the R & D capabilities and registration capabilities of API companies have become the core factors of competition. Pimpinellin factory Therefore, the R & D capabilities and registration capabilities of API companies have become the core factors of competition.